A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum- sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup ( GCIG)

被引：0
|
作者：
Pujade-Lauraine, E.
Mahner, S.
Kaern, J.
Gebski, V.
Heywood, M.
Vasey, P.
Reinthaller, A.
Vergote, I.
Pignata, S.
Ferrero, A.
机构：
[1] GINECO, Paris, France
[2] AGO OVAR, Hamburg, Germany
[3] NSGO, Oslo, Norway
[4] ANZGOG, Sydney, NSW, Australia
[5] NCIC, CTG, Vancouver, BC, Canada
[6] ANZGOG, Queensland, Australia
[7] AGO Austria, Vienna, Austria
[8] Eortc Data Ctr, Louvain, Belgium
[9] MITO, Naples, Italy
[10] MANGO, Turin, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial
    Joly, Florence
    Ray-Coquard, Isabelle
    Fabbro, Michel
    Donoghoe, Mark
    Boman, Karin
    Sugimoto, Akira
    Vaughan, Michelle
    Reinthaller, Alexander
    Vergote, Ignace
    Ferrandina, Gabriella
    Dell'Anna, Tiziana
    Huober, Jens
    Pujade-Lauraine, Eric
    GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 226 - 232
  • [22] Phase 2 study of combination therapy with liposomal doxorubicin and carboplatin in patients with relapsed, platinum sensitive ovarian cancer.
    Vorobiof, DA
    Rapoport, B
    Slabber, C
    Eek, R
    Cohen, G
    Alberts, AS
    McMichael, GB
    Raats, J
    Uys, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 471S - 471S
  • [23] Phase II study of combination therapy with pegylated liposomal doxorubicin (PLD) and carboplatin in patients (pts) with relapsed, platinum sensitive and platinum semi-sensitive ovarian cancer
    Rapoport, B. L.
    Vorobiof, D. A.
    Slabber, C.
    Cohen, G.
    Alberts, A. S.
    Hlophe, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer
    Rapoport, B. L.
    Vorobiof, D. A.
    Slabber, C.
    Alberts, A. S.
    Hlophe, H. S.
    Mohammed, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (06) : 1137 - 1141
  • [25] Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: A phase I study of the Gynecologic Oncology Group
    Rose, Peter G.
    Greer, Benjamin E.
    Horowitz, Ira R.
    Markman, Maurie
    Fusco, Nancy
    GYNECOLOGIC ONCOLOGY, 2007, 104 (01) : 114 - 119
  • [26] Phase lb safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer
    Kim, Kenneth H.
    Jelovac, Danijela
    Armstrong, Deborah K.
    Schwartz, Benjamin
    Weil, Susan C.
    Schweizer, Charles
    Alvarez, Ronald D.
    GYNECOLOGIC ONCOLOGY, 2016, 140 (02) : 210 - 214
  • [27] CARBOPLATIN (CBDCA) PLUS LIPOSOMAL DOXORUBICIN (LD) IN PLATINUM SENSITIVE OVARIAN CANCER: A PHASE II STUDY
    Cianci, Claudia
    Di Donato, Samantha
    Gadducci, Angiolo
    Cosio, Stefania
    Pastina, Ilaria
    Fanucchi, Antonio
    Orlandini, Cinzia
    Ricci, Sergio
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [28] Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
    Lai, Chyong-Huey
    Vallikad, Elizabeth
    Lin, Hao
    Yang, Lan-Yan
    Jung, Shih-Ming
    Liu, Hsueh-Erh
    Ou, Yu-Che
    Chou, Hung-Hsueh
    Lin, Cheng-Tao
    Huang, Huei-Jean
    Huang, Kuan-Gen
    Qiu, Jiantai
    Hung, Yao-Ching
    Wu, Tzu-, I
    Chang, Wei-Yang
    Tan, Kien-Thiam
    Lin, Chiao-Yun
    Chao, Angel
    Chang, Chee-Jen
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (01)
  • [29] TRABECTEDIN AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VERSUS CARBOPLATIN AND PLD IN PARTIALLY PLATINUM-SENSITIVE OVARIAN CANCER PATIENTS: INOVATYON STUDY
    Colombo, N.
    Biagioli, E.
    Copreni, E.
    Floriani, I.
    Fossati, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 457 - 457
  • [30] Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin
    Weng, Chia-Sui
    Wu, Chao-Chih
    Chen, Tze-Chien
    Chen, Jen-Ruei
    Huang, Chueh-Yi
    Chang, Chih-Long
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9899 - 9905
12345